Regulatory News
Monday, September 5, 2016
BRIEF-Galapagos gets orphan drug designation in EU for GLPG1690 in idiopathic pulmonary fibrosis
* Orphan drug designation in European Union for GLPG1690 in
idiopathic pulmonary fibrosis
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom:)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment